ILLUMINA, INC. is 3.1x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($24.84 B vs $8.09 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ILMN | BIO |
|---|---|---|
| Market cap | $24.84 B | $8.09 B |
| US-listed rank | #539 | #1070 |
| Revenue (latest FY) | $4.34B | $2.58B |
| Net income (latest FY) | $850.00M | $759.90M |
| Net margin | 19.6% | 29.4% |
| P/E (trailing FY) | 29.2 | 10.6 |
| SEC filings | 3,713 | 1,494 |
ILLUMINA, INC. is 3.1x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($24.84 B vs $8.09 B).
In their latest fiscal years, ILLUMINA, INC. reported $4.34B in revenue while Bio-Rad Laboratories, Inc. reported $2.58B.
Full pages: ILLUMINA, INC. and Bio-Rad Laboratories, Inc., or browse the full rankings.